Molecular images of neovascularization: Art for art's sake or form with a function?

Circulation

Volumn 111, Issue 24, 2005, Pages 3188-3191

  Villanueva, Flordeliza S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Echocardiography; Editorials; Imaging; Scintigraphy

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBROBLAST GROWTH FACTOR 2; MOLECULAR MARKER; TECHNETIUM 99M;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; EDITORIAL; ENDOCARDIUM; EPICARDIUM; EXERCISE TEST; HEART ARRHYTHMIA; HEART BLOOD VESSEL; HUMAN; HYDROPHILICITY; IMAGING SYSTEM; ISCHEMIA; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULARIZATION;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HUMANS; MICROBUBBLES; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 21044434058     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.542852     Document Type: Editorial

References (15)

1. Annex BH, Simons M. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc Res. 2005;65:649-655.
2. Simons M. Angiogenesis: where do we stand now? Circulation. 2005; 111:1556-1566.
3. Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol. 2001;33:379-393.
4. 3 integrin after murine hindlimb ischemia. Circulation. 2005;111:3255-3260.
5. Leong-Poi H, Christiansen J, Heppner P, Lewis CW, Klibanov AL, Kaul S, Lindner JR. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation. 2005;111:3248-3254.
6. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation. 2000;102:e73-e86.
7. Bonow RO. Contractile reserve and coronary blood flow reserve in collateral-dependent myocardium. J Am Coll Cardiol. 1999;33:705-707.
8. Burkhoff D, Jones JW, Becker LC. Variability of myocardial perfusion defects assessed by thallium-201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery. J Am Coll Cardiol. 2001;38:1033-1039.
9. Guccione S, Li KCP, Bednarski D. Molecular imaging and therapy directed at the neovasculature in pathologies. IEEE Eng Med Biol Mag. 2004;23:50-56.
10. Rupp PA, Little CD. Integrins in vascular development. Circ Res. 2001; 89:566-572.
11. Lu E, Wagner WR, Schellenberger U, Abraham JA, Klibanov AL, Woulfe SR, Csikari MM, Fischer D, Schreiner GF, Brandenburger GH, Villanueva FS. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation. 2003;108:97-103.
12. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR, Villanueva FS. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-biding peptide RRL. Cancer Res. 2005;65:533-539.
13. Linka AZ, Sklenar J, Wei K, Jayaweera AR, Skyba DM, Kaul S. Assessment of transmural distribution of myocardial perfusion with contrast echocardiography. Circulation. 1998;98:1912-1920.
14. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;59:507-521.
15. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovas Res. 2001;49:554-560.